Compare · BMGL vs CHE
BMGL vs CHE
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.74B, about 227.2x BMGL ($29.6M).
- BMGL has been more active in the news (8 items in the past 4 weeks vs 6 for CHE).
- CHE has more recent analyst coverage (7 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Chemed Corp
- Price
- $3.90+2.63%
- $511.70-0.54%
- Market cap
- $29.6M
- $6.74B
- 1M return
- -13.04%
- -
- 1Y return
- -78.62%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 8
- 6
- Recent ratings
- 0
- 7
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest BMGL
- SEC Form 6-K filed by Basel Medical Group Ltd
- Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 424B4 filed by Basel Medical Group Ltd
- Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering
- SEC Form 3 filed by new insider Hong Frederick Shieh Ming
- SEC Form EFFECT filed by Basel Medical Group Ltd
- Amendment: SEC Form F-1/A filed by Basel Medical Group Ltd
- SEC Form F-1 filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
Latest CHE
- Executive vice president Lee Spencer S exercised 12,099 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 11,160 units of Capital Stock, increasing direct ownership by 7% to 14,851 units (SEC Form 4)
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- President and CEO Mcnamara Kevin J sold $1,026,900 worth of Capital Stock (2,000 units at $513.45), decreasing direct ownership by 3% to 66,418 units (SEC Form 4)
- Vice president Hutton Thomas C exercised 4,629 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 4,270 units of Capital Stock, increasing direct ownership by 1% to 32,840 units (SEC Form 4)
- UBS initiated coverage on Chemed with a new price target
- President and CEO Mcnamara Kevin J sold $1,002,800 worth of Capital Stock (2,000 units at $501.40), decreasing direct ownership by 3% to 68,418 units (SEC Form 4)
- Roto-Rooter Buys Largest Franchisee Territory
- Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)